OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women
Lanxin Zhang, Sara Iannuzzi, Ayyappa Chaturvedula, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2753-2762
Open Access | Times Cited: 14
Lanxin Zhang, Sara Iannuzzi, Ayyappa Chaturvedula, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2753-2762
Open Access | Times Cited: 14
Showing 14 citing articles:
HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
Jeanne Marrazzo, Tao Li, Marissa Becker, et al.
JAMA (2024) Vol. 331, Iss. 11, pp. 930-930
Open Access | Times Cited: 27
Jeanne Marrazzo, Tao Li, Marissa Becker, et al.
JAMA (2024) Vol. 331, Iss. 11, pp. 930-930
Open Access | Times Cited: 27
Event-driven PrEP beyond cisgender men who have sex with men
Whitney C. Irie, Melanie R. Nicol, Meredith E. Clement, et al.
The Lancet HIV (2025)
Closed Access | Times Cited: 1
Whitney C. Irie, Melanie R. Nicol, Meredith E. Clement, et al.
The Lancet HIV (2025)
Closed Access | Times Cited: 1
Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study
Dvora Joseph Davey, Rufaro Mvududu, Nyiko Mashele, et al.
The Lancet HIV (2024) Vol. 11, Iss. 11, pp. e746-e755
Open Access | Times Cited: 4
Dvora Joseph Davey, Rufaro Mvududu, Nyiko Mashele, et al.
The Lancet HIV (2024) Vol. 11, Iss. 11, pp. e746-e755
Open Access | Times Cited: 4
Characterizing HIV seroconversions among a cohort of oral PrEP users in South Africa
Catherine Martin, Hlologelo Ramatsoma, Glory Chidumwa, et al.
Journal of the International AIDS Society (2025) Vol. 28, Iss. 2
Open Access
Catherine Martin, Hlologelo Ramatsoma, Glory Chidumwa, et al.
Journal of the International AIDS Society (2025) Vol. 28, Iss. 2
Open Access
A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomised, Factorial, Non-Inferiority Trial
David Dunn, Sheena McCormack, Sylvia Kusemererwa, et al.
(2025)
Closed Access
David Dunn, Sheena McCormack, Sylvia Kusemererwa, et al.
(2025)
Closed Access
HIV Pre-Exposure Prophylaxis
Geoffroy Liégeon, Constance Delaugerre, Jean‐Michel Molina
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 3, pp. 453-474
Closed Access | Times Cited: 3
Geoffroy Liégeon, Constance Delaugerre, Jean‐Michel Molina
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 3, pp. 453-474
Closed Access | Times Cited: 3
Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany
Daniel Schmidt, Yannick Duport, Christian Kollan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Daniel Schmidt, Yannick Duport, Christian Kollan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows non‐superiority for oral dosing, but promise as a subcutaneous implant
Hee‐yeong Kim, Lanxin Zhang, Craig W. Hendrix, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 10, pp. 1693-1706
Open Access | Times Cited: 2
Hee‐yeong Kim, Lanxin Zhang, Craig W. Hendrix, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 10, pp. 1693-1706
Open Access | Times Cited: 2
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)
Ethel D. Weld, Ian McGowan, Peter A. Anton, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 4, pp. 1131-1140
Closed Access | Times Cited: 6
Ethel D. Weld, Ian McGowan, Peter A. Anton, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 4, pp. 1131-1140
Closed Access | Times Cited: 6
Establishing adherence–concentration–efficacy thresholds of TDF–FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF–FTC Benchmark Study
Linxuan Wu, M. Saina, Clare Brown, et al.
Frontiers in Reproductive Health (2024) Vol. 6
Open Access | Times Cited: 1
Linxuan Wu, M. Saina, Clare Brown, et al.
Frontiers in Reproductive Health (2024) Vol. 6
Open Access | Times Cited: 1
Modelling the impact of initiation delay, duration and prior PrEP usage on the prophylactic efficacy of FTC/TDF-containing post-exposure prophylaxis
Lanxin Zhang, Simon Collins, Julie Fox, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lanxin Zhang, Simon Collins, Julie Fox, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Person-centered HIV PrEP for cisgender women
Maryam Shahmanesh, Natsayi Chimbindi, Frances M. Cowan
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2707-2708
Closed Access | Times Cited: 1
Maryam Shahmanesh, Natsayi Chimbindi, Frances M. Cowan
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2707-2708
Closed Access | Times Cited: 1
Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subdermal implant
H. Y. Kim, Lanxin Zhang, Craig W. Hendrix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
H. Y. Kim, Lanxin Zhang, Craig W. Hendrix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
